Social Media Ideas for Big Pharma Lawsuit

Lessons From Landmark Jury Verdict in Amitiza Reverse Payment Antitrust Case

On May 18, a federal jury in Massachusetts returned a $885 million verdict against Takeda Pharmaceuticals, finding that Takeda entered into an anticompetitive patent settlement tha...

Eli Lilly Conspiracy Claim In Compound Drug Row Challenged

A California federal court should toss part of Eli Lilly's third attempt at allegations that a telehealth company, provider group and a now-shuttered pharmacy conspired to falsely...

$885M IBS Drug Verdict Tests Pay-For-Delay Limits

The outcome in the Amitiza Antitrust Litigation is significant because it is the first jury trial win for private antitrust plaintiffs in a suit challenging a patent settlement rev...

CVS Caremark reaches settlement with FTC over insulin suit

Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost ver...

Eli Lilly Settles Mounjaro TM Suit Against Seattle Area Clinics

Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismi...

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury

The verdict is the ​first time ‌a jury has found a pharmaceutical company liable in class-action litigation over what is called a "pay-for-delay" agreement with generic rivals.

Takeda Vows Appeal of $885M Jury Verdict in ‘Pay-for-Delay’ Antitrust Case

Pharmacies and wholesalers claimed Takeda Pharmaceutical delayed generic competition from entering the market, forcing them to overpay for a gastrointestinal drug. Takeda said the...

Takeda Liable In IBS Drug Pay-For-Delay Trial

A federal jury in Boston on Monday found Takeda Pharmaceuticals conspired with a generic-drug maker to delay the launch of a generic version of Takeda's anti-constipation drug, awa...

Eli Lilly Wins Court Order in Fraud Allegations Against Florida, TN Pharmacy Groups

Eli Lilly, one of the world’s largest pharmaceutical makers, has won a federal court order against leaders of a Tennessee church and Florida and Tennessee-based pharmacy groups, af...

GEICO sues Brooklyn pharmacy over alleged $3 million in billing

Insurer seeks about $432,000 back and challenges roughly $2.53 million in pending claims

Wholesalers Say Novo Can't Duck GLP-1 Antitrust Suits

Drug buyers want a New York federal judge to preserve proposed class claims accusing Novo Nordisk of paying Teva to delay generic competition with its Victoza GLP-1 drug, arguing t...

'This Result Was Shocking': Judge Grants Directed Verdict for Pharmacies in Florida Opioid Trial

Broward County Circuit Court Judge Carol-Lisa Phillips granted a motion from Walmart, Walgreens and CVS for a directed verdict in a novel opioid trial that ended Dec. 8 in a mistri...

Progressive Oncology & Hematology’s $1.45 Million FCA Settlement Exposes Systematic Chemotherapy Drug Billing Fraud...

False Advertising Class Action Targets Pharmavite Over Supplement Marketing

A newly filed putative class action in the Northern District of California takes aim at supplement maker Pharmavite LLC, placing the company’s marketing and labeling practices unde...

DOJ’s CVS Lawsuit Looks Tough. It Won’t Fix the System.

A yearslong series of federal lawsuits against Walmart, CVS, and other pharmacies centers on opioids, insulin, prescription refills, federal reimbursements, and patient safety. Wit...

FTC, CVS unveil settlement in ongoing insulin pricing case

The Federal Trade Commission has officially inked a second settlement with one of the "Big Three" pharmacy benefit managers in an ongoing legal battle over insulin prices.

Generics Cos. Get More Freedom In High Court Patent Ruling

The U.S. Supreme Court's decision Thursday shutting down a patent case involving a generic heart drug that uses a so-called skinny label establishes a road map for generics compani...

Supreme Court Shuts Down 'Skinny Label' Drug Patent Suit

The U.S. Supreme Court on Thursday ended a patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, saying Amarin Pharm...

Gilead Owed $68M In Counterfeit Case, Magistrate Judge Says

A New York federal magistrate judge has recommended awarding $68 million to biopharmaceutical company Gilead Sciences Inc. from a group of companies it accused of producing counter...

Fine, Kaplan and Black, R.P.C. Announces Claim Forms Now Being Accepted for Class Action Settlements If You Paid or Reim...

PHILADELPHIA, July 10, 2026 /PRNewswire/ --

GEICO sues Queens pharmacy over alleged $1.2 million no-fault scheme

Topical creams billed above $2,000 a script - and a drugstore version costs about $10

False Advertising Class Action Targets Pharmavite Over Supplement Marketing

A newly filed putative class action in the Northern District of California takes aim at supplement maker Pharmavite LLC, placing the company’s marketing and labeling practices unde...

Pharmacies Hit With Injunction In Gilead Counterfeit Drug Row

A New York federal judge has issued a preliminary injunction blocking a pair of Queens pharmacies from selling any human immunodeficiency virus medications that bear the Gilead nam...

Chemical Company Chemours Agrees to $450M Settlement in PFAS Lawsuit

The lawsuit against Chemours alleged that the company illegally dumped PFAS into the Ohio River, Cape Fear River and Delaware River over the course of a decade.